Emmanuel J Favaloro: New Publication on Artificial Intelligence in Thrombosis and Hemostasis in CCLM
Emmanuel J Favaloro, Editor in Chief at Seminars in Thrombosis and Hemostasis, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Just published in an issue of Clinical Chemistry and Laboratory Medicine (CCLM).
Ably led by one of my PhD students, Mohammad A. Altememi.
Artificial intelligence and machine learning in thrombosis and hemostasis.
You may consider asking one of the authors for a copy.”
Title: Artificial intelligence and machine learning in thrombosis and hemostasis: a scoping review of clinical and laboratory applications, challenges, and future directions
Authors: Mohammad A. Altememi, Emmanuel J. Favaloro, Md Zahid Islam and Abishek. B. Santhakumar
Read the Full Article on De Gruyter Brill
Other articles featuring Emmanuel J Favaloro on Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis